Rehwald Chiropractic Pa Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1003 Lubbock Rd., Brownfield, TX 79316 Phone: 806-637-0806 Fax: 806-637-0810 |
Dr. Caitlin Sims, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1003 Lubbock Rd, Brownfield, TX 79316 Phone: 806-637-0806 Fax: 806-637-0810 |
Dr. Kiley Keith Timmons, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1003 Lubbock Rd, Brownfield, TX 79316 Phone: 806-637-0806 |
Kiley K. Timmons, D.c., P.a. Chiropractor Medicare: Medicare Enrolled Practice Location: 1003 Lubbock Rd, Brownfield, TX 79316 Phone: 806-637-0806 |
News Archive
Neurologists at Ludwig-Maximilians-Universitaet (LMU) in Munich have studied the role of the vestibular system, which controls balance, in optimizing how we direct our gaze. The results could lead to more effective rehabilitation of patients with vestibular or cerebellar dysfunction.
Genetic counselors are playing a greater role in areas of medicine in the wake of advancement in genomic technology.
Truck drivers who are frequently fatigued after work, use cell phones while driving, or have an elevated pulse pressure - a potential predictor of cardiovascular disease - may be at increased risk for getting into truck accidents, according to a study by the Rocky Mountain Center for Occupational and Environmental Health at the University of Utah School of Medicine and published in the Journal of Occupational and Environmental Medicine.
UBC researchers Jenn Jakobi and Gareth Jones, both Health and Exercise Sciences professors at UBC's Okanagan campus, recently completed a study that examined the methods used to monitor the progressive advancement of Parkinson's disease (PD)-a degenerative disease that affects the central nervous system.
Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp., providing Sorrento with a comprehensive technology platform to create a new generation of homogenous antibody drug conjugates with site-specific toxin conjugation and consistent drug-antibody ratios. With the close of the deal, Sorrento has issued an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders. Based on the closing share price on December 18, 2013, the transaction is valued at $11.3 million.
› Verified 7 days ago